Cannabis stocks (CGC, TLRY, CURLF, CRLBF, GTBIF) are rising after former President Donald Trump announced he would vote in favor of Florida's ballot measure to legalize marijuana for recreational use. Market Domination Hosts Julie Hyman and Josh Lipton report more on the story and how cannabis stocks have performed this year so far. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
Shares of cannabis companies sank on Tuesday after the U.S. Drug Enforcement Administration (DEA) postponed its cannabis reclassification hearing to Dec. 2, after the U.S. presidential election. The Department of Justice, which oversees the DEA, said Attorney General Merrick Garland recommended cannabis be reclassified as a Schedule three drug instead of Schedule one earlier this year. Schedule one is reserved for drugs with a high potential for abuse and no accepted medical use.